Cover Image

Clinical behavior of a cohort of adult women with facial acne treated with combined oral contraceptive: ethinylestradiol 20 µg/dienogest 2 mg

John Palacio-Cardona,1 Diana María Caicedo Borrero2 1Student Welfare Service – Health Area, Santiago de Cali University, 2Support for Research, Academic, Scientific and Technological Services (SEACIT), Cali, Colombia Abstract: Acne vulgaris is the most common skin disease. It af...

Full description

Saved in:

Bibliographic Details
Main Authors:	Palacio-Cardona J (Author), Caicedo Borrero DM (Author)
Format:	Book
Published:	Dove Medical Press, 2017-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hormone withdrawal-associated symptoms with ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 µg/desogestrel 150 µg (21/7 regimen)
by: Bitzer J, et al.
Published: (2015)

Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies
by: Marr J, et al.
Published: (2015)

Therapeutic non-contraceptive properties of the drug containing ethinylestradiol 0.03 mg and drospirenone 3 mg
by: Natalia V Artymuk, et al.
Published: (2019)

Quality of Life in Japanese Patients with Dysmenorrhea Treated with Ethinylestradiol 20 μg/Drospirenone 3 mg in a Real-World Setting: An Observational Study
by: Momoeda M, et al.
Published: (2020)

Adherence with ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study
by: Wiegratz I, et al.
Published: (2015)

Bleeding Pattern and Management of Unexpected Bleeding/Spotting with an Extended Regimen of a Combination of Ethinylestradiol 20 mcg and Drospirenone 3 mg
by: Bonassi Machado R, et al.
Published: (2020)

Randomized control trial to compare effects of ultra-low dose (Ethinylestradiol 20 μg or 15 μg) with low dose (Ethinylestradiol 30 μg) hormonal pills on lipid discordance in non-obese PCOS women
by: Subhankar Dasgupta, et al.
Published: (2023)

Contraception with estradiol valerate and dienogest: adherence to the method
by: Fruzzetti F, et al.
Published: (2019)

Estradiol valerate and dienogest: a new approach to oral contraception
by: Kiley JW, et al.
Published: (2011)

Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
by: Bitzer J, et al.
Published: (2011)

Efficacy, safety, and patient acceptability of the combined chlormadinone acetate-ethinylestradiol oral contraceptive
by: Serena Ferrari, et al.
Published: (2010)

Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
by: Rafie S, et al.
Published: (2013)

Determination of ethinylestradiol and levonorgestrel in oral contraceptives with HPLC methods with UV detection and UV/fluorescence detection
by: Zorica Arsova-Sarafinovska, et al.
Published: (2006)

Atherosclerosis-related biomarkers in women with endometriosis: The effects of dienogest and oral contraceptive therapy
by: Eiko Maeda, et al.
Published: (2020)

Heavy uterine bleeding in women with endometriosis and adenomyosis treated with dienogest
by: Fang-Wei Chou, et al.
Published: (2024)

Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy
by: Marelli Silvia, et al.
Published: (2009)

Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study
by: Briggs P, et al.
Published: (2016)

Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
by: Nappi RE, et al.
Published: (2014)

Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain
by: Anjeza Xholli, et al.
Published: (2021)

Information on the combined hormonal contraceptives (CHC) containing the dienogest + ethinyl estradiol combination (Jeanine®)
by: A. D. Makatsariya, et al.
Published: (2019)

Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill
by: Maurizio Guida, et al.
Published: (2010)

The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 µg/levonorgestrel 100 µg + ethinyl estradiol 10 µg
by: Sheila Krishnan, et al.
Published: (2010)

Therapeutic effects and safety profile of dienogest-containing combined oral contraceptives (a literature review)
by: V V Korennaya, et al.
Published: (2016)

Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest
by: Hiroaki Takagi, et al.
Published: (2023)

An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch
by: Zhang C, et al.
Published: (2017)

New developments in oral contraception: clinical utility of estradiol valerate/dienogest (Natazia®) for contraception and for treatment of heavy menstrual bleeding: patient considerations
by: Nelson AL
Published: (2012)

Subject Satisfaction with Trifarotene 50 μg/g Cream in the Treatment of Facial and Truncal Acne Vulgaris: A Case Series
by: Sandra M. Johnson, et al.
Published: (2020)

Dienogest in long-term treatment of endometriosis
by: Schindler AE
Published: (2011)

Hemostatic effects of kyukikyogaito in dienogest treatment
by: H. Takagi, et al.
Published: (2020)

CGRP neuropeptide levels in patients with endometriosis-related pain treated with dienogest: a comparative study
by: Shahla Chaichian, et al.
Published: (2024)

Miastenia Gravis (M.G.)
by: Orlando Restrepo Ochoa
Published: (1996)

Unilateral acne after facial palsy
by: Emilio Sudy, et al.
Published: (2018)

A microRNA focus on acne
by: Sarah Gordon, et al.
Published: (2024)

Use of oral contraceptives in the management of acne
by: Melis GB, et al.
Published: (2011)

Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study
by: Yu Q, et al.
Published: (2018)

Segmented in vitro fertilization and frozen embryo transfer in dienogest-treated patient with adenomyosis: A case report and lierature review
by: Min Feng, et al.
Published: (2022)

Unpacking the G20 Unpacking the G20 Insights from the Summit
by: Dobson, Hugo
Published: (2024)

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials
by: David F Archer, ProfMD, et al.
Published: (2019)

Examining the use of oral contraceptives in the management of acne
by: Heather L Salvaggio, et al.
Published: (2010)

Facial skin revitalization with CPM®-HA20G: an effective and safe early intervention treatment
by: Hertz-Kleptow D, et al.
Published: (2019)